Revance Therapeutics shares owned by Morgan Stanley
Quarter-by-quarter ownership of Revance Therapeutics shares owned by Morgan Stanley
from 13F filings
Historical chart of Morgan Stanley investment in Revance Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Revance Therapeutics held by Morgan Stanley consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Revance Therapeutics by Morgan Stanley
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-06-30 | $3.2M | 4.9M | 0.66 |
| 2024-03-31 | $1.0M | 1.4M | 0.73 |
| 2023-12-31 | $2.7M | 3.6M | 0.76 |
| 2023-09-30 | $2.4M | 3.0M | 0.80 |
| 2023-06-30 | $3.8M | 3.6M | 1.05 |
| 2022-12-31 | $3.5M | 3.9M | 0.91 |
| 2022-06-30 | $4.3M | 5.4M | 0.79 |
| 2022-03-31 | $4.0M | 4.2M | 0.94 |
| 2021-06-30 | $8.4M | 7.2M | 1.17 |